title: Recombinant interleukin-2-induced regression of pulmonary metastasis of renal cell carcinoma.
abstract: A patient having renal cell carcinoma with multiple pulmonary metastasis was treated with recombinant interleukin-2. Pulmonary metastatic nodes were markedly diminished. The response was maintained for 4 months. At Autopsy, many fibrotic areas in which metastatic carcinoma was thought to have previously existed and then healed were observed in the bilateral pulmonary lobes, although a few microscopically tiny metastatic lesions still remained.
authors.affiliation: Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fujioka
authors.forename: S
authors.initials: S
authors.lastname: Tanji
authors.forename: H
authors.initials: H
authors.lastname: Koike
authors.forename: K
authors.initials: K
authors.lastname: Kumagai
authors.forename: T
authors.initials: T
authors.lastname: Kubo
authors.forename: T
authors.initials: T
authors.lastname: Ohhori
authors.forename: T
authors.initials: T
authors.lastname: Satoh
authors.forename: R
authors.initials: R
authors.lastname: Satodate
mesh_terms: D002292:Carcinoma, Renal Cell / Q000556:secondary* / Q000628:therapy*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms; D008175:Lung Neoplasms / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins